CoreCap Advisors’s Globus Medical GMED Stock Holding History

CoreCap Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.7K	Buy	196 +187	+2,078%	+$14.8K	﹤0.01%	1931
2026 Q2	$711	Sell	9 -16	-64%	-$1.36K	﹤0.01%	2771
2026 Q1	$2.15K	Hold	25	–	–	﹤0.01%	2395
2025 Q4	$2.18K	Buy	+25	New	+$1.9K	﹤0.01%	2457
2025 Q2	–	Sell	-3	Closed	-$220	–	2942
2025 Q1	$220	Buy	+3	New	+$248	﹤0.01%	2936
2022 Q4	$817	Buy	+11	New	+$749	﹤0.01%	2081
2022 Q3	–	Sell	-11	Closed	-$1K	–	1132
2022 Q2	$1K	Buy	+11	New	+$723	﹤0.01%	1988
2022 Q1	–	Sell	-11	Closed	-$1K	–	1140
2021 Q4	$1K	Buy	+11	New	+$799	﹤0.01%	2128

Other funds holding GMED

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $809M AUM 17.64% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return

Covea Finance Paris, France $3.07B AUM 27.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

CoreCap Advisors's GMED Position: Q3 2026 in Review

CoreCap Advisors increased its Globus Medical (GMED) stake by 2,078% in Q3 2026, buying an estimated $14.8K and bringing the position to 196 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

CoreCap Advisors first reported a position in GMED in Q4 2021 and has held it in 8 quarters since. 115 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

CoreCap Advisors held 196 shares of Globus Medical worth $14.7K as of Q3 2026.
CoreCap Advisors bought 187 Globus Medical shares in Q3 2026, an estimated $14.8K.
Globus Medical made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1931 holding.
CoreCap Advisors first reported a position in Globus Medical in Q4 2021 and has held it in 8 quarters since.
115 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.